Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Glaukos Corp
About GKOS
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.
Find out what a historical investment in Glaukos Corp would be worth today using our GKOS stock calculator.
Market Capitalisation
$8.35B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
978.75K
High today
$144.16
Low today
$140.91
Open price
$142.27
52-week high
$146.75
52-week low
$73.16
Ready to start your investing journey with Stake?
Open an accountHow do I buy GKOS shares in Australia?
Buying GKOS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Glaukos Corp in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GKOS
What is the ticker symbol of Glaukos Corp?
The ticker symbol for Glaukos Corp is GKOS.
How much is one share of GKOS?
One share of GKOS is valued at $143.49 as of 16 May 2026.
What is the market capitalisation of Glaukos Corp GKOS?
As of 16 May 2026 Glaukos Corp has a market cap of $8.35B.
What is the 52-week high for Glaukos Corp stock?
The Glaukos Corp 52-week high stock price is $146.75.
What is the 52-week low for Glaukos Corp stock?
The Glaukos Corp 52-week low stock price is $73.16.
Can I buy GKOS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GKOS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GKOS on Stake
- Buy GKOS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GKOS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GKOS related stocks